PlainPill

GLP-1 vs Tirzepatide for weight loss

Short answer: For weight loss, more users report improvement with GLP-1 — 100% of 6 reports, versus 94% of 206 for Tirzepatide.

GLP-1 has 1,037 meta-analyses and 1,604 randomized trials on PubMed; Tirzepatide has 214 and 132.

Based on 28 reports about GLP-1 and 428 about Tirzepatide. Not medical advice.

GLP-1
Medication
Tirzepatide
Medication
Users say it helped78%helped14 reports · few reports75%helped287 reports · high confidence
Verdict
Mostly positive
Mostly positive
ResearchAResearch: StrongAResearch: Strong
Meta-analyses / RCTs1,037 / 1,604214 / 132
Mainly used for
Weight loss
% reporting improvement
100% (6)94% (206)
Appetite
% reporting improvement
—84% (79)
Energy
% reporting improvement
—44% (32)
Mood
% reporting improvement
—63% (27)
Performance
% reporting improvement
—83% (12)
Common side effectshair loss, difficulty recovering, stomach issuesnausea, fatigue, anhedonia, constipation
Typical dose reportedNot listedNot listed
GLP-1
Latest review conclusion

Potent GLP-1 RAs, such as tirzepatide and semaglutide, demonstrate greater overall weight loss but are associated with a significant reduction in lean mass.

Metabolism, 2025 ↗
What a user said
“I felt better, for certain. Think the insulin clearing the excess sugar's really imrove your well being.”
Full GLP-1 profile →
Tirzepatide
Latest review conclusion

This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.

Pharmacol Res, 2021 ↗
What a user said
“Tirzepatide works so well! Do some research in the r/peptides subreddit and the r/tirzepatide subreddit. It's the most effective thing I've ever seen for appetite suppressant.”
Full Tirzepatide profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate